Hemofiltration system for the post traumatic treatment of hyperkalemia in austere conditions
Artificial Organs · 2025
DOI: 10.1111/aor.14919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Meredith Haanstad und 7 weiteren Autor:innen. Beteiligte Einrichtung: TDA Research, Inc., Wheat Ridge, Colorado, USA. Hauptthemen laut MEDLINE: Hyperkalemia, Hemofiltration, Wounds and Injuries. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Hyperkalemia, the buildup of serum potassium to levels >6 mEq L −1 , has been a recognized complication of combat injuries such as acute kidney injury since World War II. Currently, renal replacement therapy (RRT) serves as the standard of care for hyperkalemic patients who fail to respond to medical management. However, RRT is difficult to administer in combat settings, and the time between evacuation and RRT is critical in preventing post‐traumatic hyperkalemia. Therefore, the need for portable, easily operable hemofiltration technology is pressing to improve the survival of hyperkalemic patients in austere settings.
Methods
In this manuscript, we present extra‐corporeal direct contact and hemodialysis filtration systems for treating severe hyperkalemia and tested the efficacy, biocompatibility, and performance of a zeolite‐based renal RRT. We tested the uptake capacity of an adsorbent zeolite optimized for the selective binding and removal of potassium in various mediums, including dialysate, bovine serum, and whole bovine sodium heparinized blood. Results and Conclusions Our results show that we can restore physiological normokalemic levels within just 2 h of testing and maintain these levels for 6 h. Furthermore, calcium and sodium levels were maintained within normal physiological ranges, confirming the selectivity of our sorbent material for potassium binding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- TDA Research, Inc., Wheat Ridge, Colorado, USA.
- Division of Cardiovascular Disease, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Biomedical Engineering, School of Engineering, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Palaniappan Sethu, Ambalavanan Jayaraman
Förderung
- NIBIB NIH HHS
- NIDDK NIH HHS
- NIH HHS
- Defense Health Agency
- National Institutes of Health
Zitieren
APA
Haanstad, M., Seeley, L. D., Srinivas, T., Chamot, M., Haanstad, T., Marotta, C., Sethu, P., & Jayaraman, A. (2025). Hemofiltration system for the post traumatic treatment of hyperkalemia in austere conditions. Artificial Organs. https://doi.org/10.1111/aor.14919
Vancouver
Haanstad M, Seeley LD, Srinivas T, Chamot M, Haanstad T, Marotta C, et al. Hemofiltration system for the post traumatic treatment of hyperkalemia in austere conditions. Artificial Organs. 2025. doi:10.1111/aor.14919
BibTeX
@article{Haanstad2025,
author = {Haanstad, Meredith and Seeley, Leslie D and Srinivas, Tara and Chamot, Matthew and Haanstad, Trevor and Marotta, Christopher and Sethu, Palaniappan and Jayaraman, Ambalavanan},
title = {Hemofiltration system for the post traumatic treatment of hyperkalemia in austere conditions},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14919}
}
EUVIMED